HydrochlorothiazideThiazidesSodium Chloride Symporter InhibitorsAntihypertensive AgentsDiureticsBenzothiadiazinesHypertensionChlorthalidoneDrug CombinationsAmlodipineBlood PressureNot-For-Profit Insurance PlansBendroflumethiazideDrug Therapy, CombinationSodium Chloride SymportersAtenololTriamtereneAraliaTetrazolesAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersHydralazineMethyldopaAngiotensin II Type 1 Receptor BlockersHypokalemiaCaptoprilEnalaprilIndapamideBlood Pressure Monitoring, AmbulatoryBenzimidazolesLisinoprilLosartanDrug UtilizationDouble-Blind MethodAdrenergic beta-AntagonistsDrug SynergismBlood Pressure DeterminationRats, Inbred SHRTreatment OutcomeDrug PrescriptionsDrug InteractionsDoxazosinTrichlormethiazideKidney CalculiBiphenyl CompoundsAngiotensin Receptor AntagonistsValineFurosemideDose-Response Relationship, DrugReninHypertension, RenalPotassiumBenzoatesUric AcidDihydropyridinesTime FactorsImidazolesClinical Trials as TopicCilazaprilSpironolactoneIndenesNifedipineNitrendipineFosinoprilRenin-Angiotensin SystemSystoleGuanabenzReserpineHypertrophy, Left VentricularTabletsClonidineHeart RateMetoprololRisk FactorsKidneyBisoprololHypertension, RenovascularPatient ComplianceProspective StudiesPropranololRats, Inbred WKYEthics ConsultationCardiovascular DiseasesAldosteroneAcebutololRandom AllocationFumaratesMinoxidilDihydralazineRandomized Controlled Trials as TopicNordefrinEthacrynic AcidAdrenergic alpha-AntagonistsAlbuminuriaDiastolePulseAfrican Continental Ancestry GroupPhenoxyacetatesDrug EvaluationPropanolamines